CAR 在非 B 细胞恶性肿瘤中停滞了吗?我们身处何处,又将去向何方? Have CARs stalled for non-B-cell malignancies? Where are we, and where are we going? PubMed 2025/12/05 发表Hematology Am Soc Hematol Educ ProgramQ1 · IF 3.7(JCR 2025) 靶点:CD7靶点:CD5技术:CAR-T技术:造血干细胞技术:基因编辑急性淋巴细胞白血病急性髓系白血病
CD5 缺失增强过继性 T 细胞治疗的抗肿瘤活性 CD5 deletion enhances the antitumor activity of adoptive T cell therapies. PubMed 2024/07/19 发表Sci ImmunolQ1 · IF 16.4(JCR 2025) 靶点:CD5技术:CAR-T技术:基因编辑淋巴瘤地区:美国
微流控细胞转染装置整合至基因编辑 CAR-T 细胞生产流程的开发 Development of a microfluidic cell transfection device into gene-edited CAR T cell manufacturing workflow. PubMed 2023/11/07 发表Lab ChipQ1 · IF 6.3(JCR 2025) 靶点:CD19靶点:CD5技术:CAR-T技术:基因编辑白血病地区:美国